AU Patent

AU2019406803B2 — Organic compounds

Assigned to Intra Cellular Therapies Inc · Expires 2025-04-24 · 1y expired

What this patent protects

The invention relates to particular prodrugs and analogs of (3α,5α)-3-hydroxy-21-(1

USPTO Abstract

The invention relates to particular prodrugs and analogs of (3α,5α)-3-hydroxy-21-(1

Drugs covered by this patent

Patent Metadata

Patent number
AU2019406803B2
Jurisdiction
AU
Classification
—
Expires
2025-04-24
Drug substance claim
No
Drug product claim
No
Assignee
Intra Cellular Therapies Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.